Secondary hyperparathyroidism in CKD contributes to increased bone turnover by releasing calcium and phosphate, which can contribute to VC and indirectly influence FGF 23 and sclerostin regulation. This evidence concerns the gene SOST and secondary hyperparathyroidism.